|
2025 Conference Publication Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical TrialMackintosh, J., Wells, J., Lutzky, V., Yerkovich, S.T., Yeh, R., Hsu, A., Pickett, H., Pietsch, M., Cooper, B., Enever, D., Bancroft, S., Apte, S., Tan, M., Dickinson, J., Lucas, S., Selvadurai, H., Grainge, C., Hopkins, P., Glaspole, I., Reynolds, P.N., Wrobel, J.P., Goh, N., Corte, T.J. and Chambers, D. (2025). Efficacy and Safety of Danazol in Pulmonary Fibrosis Associated With Short Telomeres: A Phase 2 Randomized Clinical Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a1010 |
|
2025 Journal Article Epstein Barr Virus Quantitative Polymerase Chain Reaction Monitoring in Lung and Bone Marrow Transplant Patients to Predict Post-Transplant Lymphoproliferative Disorder: A Systematic ReviewDivithotawela, Chandima, Lee, Shawn Z., Schulz, Michael and Chambers, Daniel C. (2025). Epstein Barr Virus Quantitative Polymerase Chain Reaction Monitoring in Lung and Bone Marrow Transplant Patients to Predict Post-Transplant Lymphoproliferative Disorder: A Systematic Review. Transplantation Proceedings, 57 (5), 931-939. doi: 10.1016/j.transproceed.2025.03.008 |
|
2025 Conference Publication High Intensity Interval Training in Patients With Interstitial Lung DiseaseDowman, L., May, A., Hill, C.J., Bondarenko, J., Spencer, L., Morris, N., Alison, J.A., Walsh, J., Khor, Y.H., Goh, N.S.L., Corte, T.J., Glaspole, I., Chambers, D., McDonald, C. and Holland, A.E. (2025). High Intensity Interval Training in Patients With Interstitial Lung Disease. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a1038 |
|
2025 Conference Publication Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Sham-Controlled TrialHolland, A.E., Hoffman, M., Corte, T.J., Chambers, D., Palmer, A., Ekstrom, M.P., Glaspole, I., Goh, N. and McDonald, C.F. (2025). Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Sham-Controlled Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a2907 |
|
2025 Journal Article Towards early prediction of chronic allograft dysfunction using molecular biomarkersBell, Peter T. and Chambers, Daniel C. (2025). Towards early prediction of chronic allograft dysfunction using molecular biomarkers. The Journal of Heart and Lung Transplantation, 44 (3), 329-330. doi: 10.1016/j.healun.2024.11.001 |
|
2025 Journal Article Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantationStewart, Adam G. and Chambers, Daniel C. (2025). Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation. The Journal of Heart and Lung Transplantation, 44 (3), 435-436. doi: 10.1016/j.healun.2024.11.043 |
|
2025 Journal Article Silicosis research priorities for health care, research, and health and safety professionals, and for people exposed to silica in Australia: a research priority setting exerciseBarnes, Hayley, Mathieu, Sharna, Glass, Deborah C, Sim, Malcolm R, Fritschi, Lin, Dickinson, Joanne L, Chambers, Daniel C, Driscoll, Tim R, Edwards, Graeme, LaBranche, Nikky, Jones, Catherine, Bourke, Jane E, Hoy, Ryan F, Jenkins, Christine R, Apte, Simon, Holland, Anne and Tikellis, Gabriella (2025). Silicosis research priorities for health care, research, and health and safety professionals, and for people exposed to silica in Australia: a research priority setting exercise. Medical Journal of Australia, 223 (5) mja2.70013, 257-264. doi: 10.5694/mja2.70013 |
|
2024 Journal Article Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsNeller, Michelle A., Ambalathingal, George R., Hamad, Nada, Sasadeusz, Joe, Pearson, Rebecca, Holmes-Liew, Chien-Li, Singhal, Deepak, Tunbridge, Matthew, Ng, Wei Yang, Sharplin, Kirsty, Moore, Andrew, Deambrosis, David, Soosay-Raj, Trisha, McNaughton, Peter, Whyte, Morag, Fraser, Chris, Grigg, Andrew, Kliman, David, Bajel, Ashish, Cummins, Katherine, Dowling, Mark, Yeoh, Zhi Han, Harrison, Simon J., Khot, Amit, Tan, Sarah, Roos, Izanne, Koo, Ray Mun, Dohrmann, Sara, Ritchie, David ... Khanna, Rajiv (2024). Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years. Nature Communications, 15 (1) 10339, 1-12. doi: 10.1038/s41467-024-54595-2 |
|
2024 Journal Article Silicosis—Where to from here?Barnes, Hayley and Chambers, Daniel C. (2024). Silicosis—Where to from here?. Respirology, 29 (12), 1020-1022. doi: 10.1111/resp.14853 |
|
2024 Journal Article Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsDousset, Lea, Chambers, Daniel C., Webster, Angela, Isbel, Nicole, Campbell, Scott, Duarte, Carla, Collins, Louisa, Damian, Diona, Tseng, Anne, Karlsen, Emma, Ilinsky, Olga Victoria, Brown, Susan, Schaider, Helmut, Soyer, H. Peter, Ospino, Daniel Ariza, Hogarth, Sam, Chong, Alvin H., Mar, Victoria, McKenzie, Scott, Gin, Douglas, Fernandez-Penas, Pablo, Kern, Johannes S., Loewe, Katja, Roy, Edwige, Herschtal, Alan and Khosrotehrani, Kiarash (2024). Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients. Trials, 25 (1) 789. doi: 10.1186/s13063-024-08619-3 |
|
2024 Journal Article Closing the Loop on Diagnostic Testing in Interstitial Lung DiseaseChambers, Daniel C. and Mackintosh, John A. (2024). Closing the Loop on Diagnostic Testing in Interstitial Lung Disease. Chest, 166 (5), 909-910. doi: 10.1016/j.chest.2024.08.001 |
|
2024 Journal Article Iron Alters the Transcriptome and Volatile Organic Compounds in the BAL of Patients with SilicosisAloe, Christian Anthony, Goh, Nicole Soo Leng, Wang, Hao, McQualter, Jonathan Luke, Doomun, Sheik Nadeem Elahee, De Souza, David, Pujari, Reshma, Papagianis, Paris Claris, Apte, Simon Hall, Barnes, Hayley, Vlahos, Ross, McDonald, Christine Faye, Hoy, Ryan Francis, Chambers, Daniel Charles, Leong, Tracy Li-Tsein and Bozinovski, Steven (2024). Iron Alters the Transcriptome and Volatile Organic Compounds in the BAL of Patients with Silicosis. American Journal of Respiratory Cell and Molecular Biology, 71 (5), 617-621. doi: 10.1165/rcmb.2024-0181le |
|
2024 Journal Article Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung diseaseLi, Andrew, Teoh, Alan, Troy, Lauren, Glaspole, Ian, Wilsher, Margaret L., de Boer, Sally, Wrobel, Jeremy, Moodley, Yuben P., Thien, Francis, Gallagher, Henry, Galbraith, Michelle, Chambers, Daniel C., Mackintosh, John, Goh, Nicole, Khor, Yet Hong, Edwards, Adrienne, Royals, Karen, Grainge, Christopher, Kwan, Benjamin, Keir, Gregory J., Ong, Chong, Reynolds, Paul N., Veitch, Elizabeth, Chai, Gin Tsen, Ng, Ziqin, Tan, Geak Poh, Jackson, Dan, Corte, Tamera and Jo, Helen (2024). Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease. Thorax, 79 (11), 1-9. doi: 10.1136/thorax-2024-221813 |
|
2024 Journal Article Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killingPham, Amy, Tan, Kellynn K. Y., Ledger, Emma L., Smith, Daniel J., Reid, David W., Burr, Lucy, Chambers, Daniel C. and Wells, Timothy J. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology, 14 1426773, 1426773. doi: 10.3389/fcimb.2024.1426773 |
|
2024 Journal Article Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panelLuong, Me‐Linh, Nakamachi, Yoshiko, Silveira, Fernanda P., Morrissey, Catherine O., Danziger‐Isakov, Lara, Verschuuren, Erik A. M, Wolfe, Cameron R., Hadjiliadis, Denis, Chambers, Daniel C., Patel, Jignesh K., Dellgren, Goran, So, Miranda, Verleden, Geert M., Blumberg, Emily A., Vos, Robin, Perch, Michael, Holm, Are M., Mueller, Nicholas J., Chaparro, Cecilia and Husain, Shahid (2024). Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transplant Infectious Disease, 26 (3) e14251, 1-16. doi: 10.1111/tid.14251 |
|
2024 Conference Publication Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary FibrosisZhang, L.-Y., Apte, S., Lutzky, V., Groves, P., Tan, M., de Silva, T.A., Nguyen, Q., Powell, J., Chambers, D. and O'Sullivan, B. (2024). Cellular Genomics of Bronchoalveolar Lavage Reveals Insight into Mechanisms of Human Pulmonary Fibrosis. American Thoracic Society 2024 International Conference, San Diego, CA United States, 17-22 May 2024. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2580 |
|
2024 Journal Article Exertional desaturation during the 6-minute walk test versus daily life in people with fibrotic interstitial lung diseaseHoffman, Mariana, Burge, Angela T., Wong, Nick, McDonald, Christine F., Chambers, Daniel C., Glaspole, Ian, Mackintosh, John A., Ekstrom, Magnus, Sköld, Magnus, Goh, Nicole SL., Corte, Tamera J. and Holland, Anne E. (2024). Exertional desaturation during the 6-minute walk test versus daily life in people with fibrotic interstitial lung disease. CHEST, 165 (3), 632-635. doi: 10.1016/j.chest.2023.08.024 |
|
2024 Journal Article Immunological landscapes in lung transplantation: Insights from T cell profiling in BAL and PBMCde Silva, Tharushi Ayanthika, Apte, Simon, Voisey, Joanne, Spann, Kirsten, Tan, Maxine, Chambers, Daniel and O’Sullivan, Brendan (2024). Immunological landscapes in lung transplantation: Insights from T cell profiling in BAL and PBMC. International Journal of Molecular Sciences, 25 (5) 2476, 1-16. doi: 10.3390/ijms25052476 |
|
2024 Journal Article Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionMackintosh, John A., Keir, Gregory, Troy, Lauren K., Holland, Anne E., Grainge, Christopher, Chambers, Daniel C., Sandford, Debra, Jo, Helen E., Glaspole, Ian, Wilsher, Margaret, Goh, Nicole S. L., Reynolds, Paul N., Chapman, Sally, Mutsaers, Steven E., de Boer, Sally, Webster, Susanne, Moodley, Yuben and Corte, Tamera J. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology, 29 (2), 105-135. doi: 10.1111/resp.14656 |
|
2024 Journal Article Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomesWalters, Samuel, Yerkovich, Stephanie, Hopkins, Peter M., Leisfield, Trish, Winks, Lesleigh, Chambers, Daniel C. and Divithotawela, Chandima (2024). Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomes. JHLT Open, 3 100043, 1-7. doi: 10.1016/j.jhlto.2023.100043 |
